1. Committee for Proprietary Medicinal Products, Intramuscular immunoglobulins: nucleic acid amplification tests for HCV RNA detection, European Agency for the Evaluation of Medicinal Products, 1995, CPMP/117/95 final
2. Committee for Proprietary Medicinal Products, Note for guidance on plasma derived medicinal products: the introduction of genomic amplification technology for plasma pool testing, European Agency for the Evaluation of Medicinal Products, 1998, CPMP/BWP/390/97
3. Feasibility and efficacy routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus and HIV-1 in a blood bank setting;Roth;Lancet,1999
4. The risk of transfusion-transmitted viral infections;Schreiber;N Eng J Med,1996